Efficacy/Safety of Low-/High-Dose Perampanel as First Adjunctive Therapy in Patients With Focal-Onset Seizures: Post Hoc Analysis of the FAME Study

被引:0
|
作者
Seo, Dae Won [1 ]
Lee, JiWoong [2 ]
Dash, Amitabh [3 ]
Lee, Sang Kun [4 ]
Lee, Sang-Ahm [5 ]
Malhotra, Manoj [6 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Eisai Korea Inc, Seoul, South Korea
[3] Eisai Singapore Pte Ltd, Singapore, Singapore
[4] Seoul Natl Univ Hosp, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[6] Eisai Inc, Woodcliff Lake, NJ USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
201
引用
收藏
页码:51 / 51
页数:1
相关论文
共 50 条
  • [21] Study 512 Design: Perampanel as first adjunctive therapy in patients aged ≥12 years with focal-onset seizures or generalised tonic-clonic seizures associated with genetic generalised epilepsy
    Burd, S.
    Assenza, G.
    Quintas, S.
    Gil Lopez, F. J.
    Wagner, J.
    Patten, A.
    Sainz-Fuertes, R.
    Lagarde, S.
    Sejbaek, T.
    Vlasov, P.
    Kharkovskiy, V.
    Lebedeva, A.
    EPILEPSIA, 2023, 64 : 293 - 293
  • [22] Efficacy and safety of adjunctive perampanel 4 mg/day in patients aged 4-<12 years with focal-onset seizures or generalised tonic-clonic seizures
    Moretz, Katherine
    Malhotra, Manoj
    Patten, Anna
    Ngo, Leock Y.
    EPILEPSIA, 2021, 62 : 269 - 269
  • [23] Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (aged 4 to <12 years) with inadequately controlled focal-onset seizures: Japanese subgroup analysis
    Omatsu, Hirowo
    Watanabe, Toshihide
    Kira, Ryutaro
    Ishiba, Kaeko
    Patten, Anna
    Takase, Takao
    Ngo, Leock Y.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023, 110 : 109 - 116
  • [24] Seizure freedom in patients with focal to bilateral tonic-clonic seizures (FBTCS) during FAME: A post hoc analysis of low-dose maintenance perampanel
    Lee, Sang Kun
    Malhotra, Manoj
    Seo, Dae Won
    Lee, Sang-Ahm
    Dash, Amitabh
    Lee, JiWoong
    EPILEPSIA, 2021, 62 : 49 - 49
  • [25] A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization
    Trinka, Eugen
    Tsong, Wan
    Toupin, Sydney
    Patten, Anna
    Wilson, Katy
    Isojarvi, Jaana
    James, Daniel
    EPILEPSY RESEARCH, 2020, 166
  • [26] Efficacy and safety of perampanel as early add-on therapy in Chinese patients with focal-onset seizures: a multicenter, open-label, single-arm study
    Gao, Lehong
    Lu, Qiang
    Wang, Zan
    Yue, Wei
    Wang, Guoping
    Shao, Xiaoqiu
    Guo, Yi
    Yi, Yonghong
    Hong, Zhen
    Jiang, Yuwu
    Xiao, Bo
    Cui, Guiyun
    Gao, Feng
    Hu, Jiasheng
    Liang, Jianmin
    Zhang, Meiyun
    Wang, Yuping
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [27] Long-term safety and efficacy of adjunctive perampanel in pediatric patients (ages 4 to <12 years) with inadequately controlled focal-onset seizures or generalized tonic-clonic seizures
    Flamini, Robert
    Fogarasi, Andras
    Omatsu, Hirowo
    Milh, Mathieu
    Phillips, Steven
    Patten, Anna
    Takase, Takao
    Ngo, Leock Y.
    EPILEPSIA, 2025,
  • [28] Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures
    Hixson, John
    Gidal, Barry
    Pikalov, Andrei
    Zhang, Yi
    Mehta, Darshan
    Blum, David
    Cantu, David
    Grinnell, Todd
    EPILEPSY RESEARCH, 2021, 171
  • [29] A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanel
    Krauss, Gregory L.
    Ben-Menachem, Elinor
    Wechsler, Robert T.
    Patten, Anna
    Williams, Betsy
    Laurenza, Antonio
    Malhotra, Manoj
    EPILEPSY RESEARCH, 2021, 174
  • [30] Efficacy and safety of perampanel monotherapy in Chinese patients with focal-onset seizures: A single-center, prospective, real-world observational study
    Ma, Haiyan
    Zhu, Haitao
    Chen, Fangqing
    Yang, Yiqing
    Qu, Xuefeng
    Xu, Honghao
    Yang, Lu
    Zhang, Rui
    EPILEPSIA OPEN, 2023, 8 (04) : 1474 - 1483